Menopause preparedness for patient, provider, and policymaker

October 27, 2021

A more standardized approach to menopause preparedness, including educating both patients and providers, is needed to improve care and quality of life for individuals during and after menopause, according to a study in the journal Menopause.

Poll: Has the Texas abortion ban impacted the way you treat patients?
Community-based activity programs benefit underserved breast cancer survivors
The impact of diet on IBS
Nemvaleukin alfa plus pembrolizumab gets fast track status for platinum-resistant ovarian cancer

Agenus Withdraws BLA for Balstilimab in Metastatic Cervical Cancer

October 25, 2021

The immuno-oncology company Agenus has made the decision to withdraw its biologic license application for the use of the PD-1 inhibitor balstilimab in patients with recurrent or metastatic cervical cancer who experienced disease progression on, or after, chemotherapy.